Skip to main content

UBS Group AG

Position in CNTX — Context Therapeutics Inc.

CIK 1610520 ZURICH, V8

Position in CNTX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$15,613
-$599 QoQ
Shares Held
28,183
+355.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 79 holders
Holding Since
Jun 2022
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CNTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,180 across 562 Biotechnology names. CNTX ranks #434 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CNTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,613 28,183
2026-03-31 $16,212 6,188
2025-12-31 $720 490
2025-09-30 $7,153 7,382
2025-06-30 $242 370
2025-03-31 $264 432
2024-12-31 $734,084 699,129
2024-09-30 $3,365 1,717
2023-12-31 $10,723 9,490
2023-03-31 $3,241 5,767
2022-12-31 $1,796 2,755
2022-06-30 $7,689 3,627